Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Current Leases: 2020-2024

Historic Current Leases for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $2.5 million.

  • Tango Therapeutics' Current Leases rose 8.35% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 8.35%. This contributed to the annual value of $2.5 million for FY2024, which is 17.87% up from last year.
  • Latest data reveals that Tango Therapeutics reported Current Leases of $2.5 million as of FY2024, which was up 17.87% from $2.1 million recorded in FY2023.
  • Over the past 5 years, Tango Therapeutics' Current Leases peaked at $2.5 million during FY2024, and registered a low of $959,000 during FY2020.
  • Its 3-year average for Current Leases is $2.1 million, with a median of $2.1 million in 2023.
  • Data for Tango Therapeutics' Current Leases shows a peak YoY surged of 56.73% (in 2021) over the last 5 years.
  • Over the past 5 years, Tango Therapeutics' Current Leases (Yearly) stood at $959,000 in 2020, then skyrocketed by 56.73% to $1.5 million in 2021, then rose by 17.76% to $1.8 million in 2022, then climbed by 17.63% to $2.1 million in 2023, then grew by 17.87% to $2.5 million in 2024.